>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Newsroom

News of the Hour News Reader Market News Stock News Topics Social Sentiments Market TV Press Releases
Articles > Cannabiz pot stocks: Top gainers ABBV, XXII

Cannabiz pot stocks: Top gainers ABBV, XXII

By KlickAnalytics Data Insights  |   August 31, 2026 04:40PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Cannabiz pot stocks' theme.

AbbVie Inc. (ABBV)
ABBV is trading UP for the last 1 days, and it at trading at $256.69 with volume of 1,854,290 and a one day change of $1.21 (0.47%). AbbVie Inc. has a 52-week low of 189.40 and a 52-week high of $267.47. The business's 50-day moving average price is $251.18 and its 200 day moving average price is $224.98. The firm has a market cap of $451 million, a P/E ratio of 71.98, and a beta of 0.35.

Top news headlines for ABBV

  • XLV bundles the entire healthcare sector into one tidy package, but its cap-weighted structure quietly siphons off the income that dividend investors came for. Three stocks already inside the fund tell a very different yield story.
  • AbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advances in immunology, diabetes and cardiovascular care.
  • NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
  • Abacus FCF Advisors LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 58,634 shares of the company's stock, valued at approximately $14,755,000. AbbVie comprises about 2.7% of Abacus FCF
  • Csenge Advisory Group acquired a new position in AbbVie Inc. (NYSE: ABBV) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 25,158 shares of the company's stock, valued at approximately $6,331,000. Other institutional investors and hedge funds have also bought and sold

    • For more information on ABBV:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • 22nd Century Group, Inc. (XXII)
    XXII is trading UP for the last 2 days, and it at trading at $3.14 with volume of 13,655 and a one day change of $0.01 (0.32%). 22nd Century Group, Inc. has a 52-week low of 0.27 and a 52-week high of $11.37. The business's 50-day moving average price is $4.14 and its 200 day moving average price is $2.89. The firm has a market cap of $0 million, a P/E ratio of -0.03, and a beta of 2.07.

    For more information on XXII:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

    Market News ×
    Loading news…